Literature DB >> 2623043

Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis.

H O Pettit1, J B Justice.   

Abstract

The extracellular dopamine (DA) concentration in the nucleus accumbens was measured following intravenous cocaine administration. The DA concentration increased in a dose-dependent manner following a single intravenous infusion of cocaine. The concentration of DA was observed to increase and stabilize in a schedule-dependent manner when cocaine was repeatedly administered 15-, 5- and 2.5-minute intervals. When cocaine was administered in regular intervals to animals by an experimenter or when animals self-administered cocaine. DA concentrations stabilized substantially above the basal level. These data support research that suggests that reinforcing properties of cocaine are primarily mediated by DA release in the nucleus accumbens. The data and pharmacokinetic calculations indicate that the DA concentration increases for a short period following each infusion. It then falls to a level until the animal again self-administers the drug. Animals may regulate self-administration responding for cocaine in order to maintain DA levels above a certain level, yet titrate responding so that aversive effects are not produced.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2623043     DOI: 10.1016/0091-3057(89)90291-8

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  107 in total

1.  Impact of self-administered cocaine and cocaine cues on extracellular dopamine in mesolimbic and sensorimotor striatum in rhesus monkeys.

Authors:  C W Bradberry; R L Barrett-Larimore; P Jatlow; S R Rubino
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

2.  Firing rate of nucleus accumbens neurons is dopamine-dependent and reflects the timing of cocaine-seeking behavior in rats on a progressive ratio schedule of reinforcement.

Authors:  S M Nicola; S A Deadwyler
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

3.  Differentiating the rapid actions of cocaine.

Authors:  Roy A Wise; Eugene A Kiyatkin
Journal:  Nat Rev Neurosci       Date:  2011-06-02       Impact factor: 34.870

4.  Blockade of substantia nigra dopamine D1 receptors reduces intravenous cocaine reward in rats.

Authors:  Matthew G Quinlan; Ruth Sharf; David Y Lee; Roy A Wise; Robert Ranaldi
Journal:  Psychopharmacology (Berl)       Date:  2004-02-07       Impact factor: 4.530

5.  Characterization of dopamine D1 and D2 receptor function in socially housed cynomolgus monkeys self-administering cocaine.

Authors:  Paul W Czoty; Drake Morgan; Erin E Shannon; H Donald Gage; Michael A Nader
Journal:  Psychopharmacology (Berl)       Date:  2004-02-07       Impact factor: 4.530

6.  Discrete cell gene profiling of ventral tegmental dopamine neurons after acute and chronic cocaine self-administration.

Authors:  Eric Backes; Scott E Hemby
Journal:  J Pharmacol Exp Ther       Date:  2003-09-09       Impact factor: 4.030

7.  Neonatal isolation enhances maintenance but not reinstatement of cocaine self-administration in adult male rats.

Authors:  Xiang Yang Zhang; Hayde Sanchez; Priscilla Kehoe; Therese A Kosten
Journal:  Psychopharmacology (Berl)       Date:  2004-07-16       Impact factor: 4.530

Review 8.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

9.  Ventral tegmental area neurons are either excited or inhibited by cocaine's actions in the peripheral nervous system.

Authors:  C A Mejías-Aponte; E A Kiyatkin
Journal:  Neuroscience       Date:  2012-01-20       Impact factor: 3.590

10.  Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys.

Authors:  R D Spealman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.